FDA approves Novo Nordisk’s Wegovy for cardiovascular risk reduction in adults with obesity

The U.S. Food and Drug Administration (FDA) has recently granted an additional indication for Novo Nordisk's Wegovy, a milestone in medical advancements aimed at combating ... Read More